Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy.

MLA

Orleth, Annette, et al. “Simultaneous Targeting of VEGF-Receptors 2 and 3 with Immunoliposomes Enhances Therapeutic Efficacy.” Journal of Drug Targeting, vol. 24, no. 1, 2016, pp. 80–89. EBSCOhost, https://doi.org/10.3109/1061186X.2015.1056189.

APA

Orleth, A., Mamot, C., Rochlitz, C., Ritschard, R., Alitalo, K., Christofori, G., & Wicki, A. (2016). Simultaneous targeting of VEGF-receptors 2 and 3 with immunoliposomes enhances therapeutic efficacy. Journal of Drug Targeting, 24(1), 80–89. https://doi.org/10.3109/1061186X.2015.1056189

Chicago

Orleth, Annette, Christoph Mamot, Christoph Rochlitz, Reto Ritschard, Kari Alitalo, Gerhard Christofori, and Andreas Wicki. 2016. “Simultaneous Targeting of VEGF-Receptors 2 and 3 with Immunoliposomes Enhances Therapeutic Efficacy.” Journal of Drug Targeting 24 (1): 80–89. doi:10.3109/1061186X.2015.1056189.